Beranda › Multiple Myeloma Smoldering
Uji klinis Multiple Myeloma Smoldering yang merekrut di AS
20 studi untuk Multiple Myeloma Smoldering merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Boston, MA6 studi
- New York City, NY6 studi
- Atlanta, GA5 studi
- Denver, CO3 studi
- Durham, NC3 studi
- Houston, TX3 studi
- Salt Lake City, UT3 studi
- Columbus, OH3 studi
- Edison, NJ3 studi
Berdasarkan negara bagian
- Colorado3 studi
- Florida4 studi
- Georgia5 studi
- Massachusetts6 studi
- Michigan4 studi
- New Jersey3 studi
- New York8 studi
- North Carolina4 studi
- Ohio3 studi
- Texas4 studi
- Utah3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06768489A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT03937635Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT05469893CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06644625A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06140524Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT04776395Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT02269592FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT07446777Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT02726750A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT05640843Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT05136807Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05361694Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06212323Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Des 2025 · NCT05312255Registry for Adults With Plasma Cell Disorders (PCD's)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Nov 2025 · NCT03717844A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Nov 2025 · NCT06055894The Indiana Myeloma Registry
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT03616483Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Menerima pesertaStudi observasional
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2025 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2025 · NCT05597345Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.